Command Palette

Search for a command to run...

NIYATILEAS

18.3-1.35%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Veerhealth Care Ltd. exhibits weak financial performance compared to its peers, with no revenue or earnings growth, and a high PE ratio suggesting overvaluation. In contrast, Sun Pharmaceutical Industries and Cipla Ltd. are strong overall performers with solid profitability, growth, and attractive valuation metrics, making them the sector leaders.

Key Points
  • Veerhealth Care Ltd. shows no growth in revenue or earnings, and has the highest PE ratio of 99.69.
  • Sun Pharmaceutical and Cipla Ltd. demonstrate strong revenue growth and profitability, making them top performers.
  • Divi's Laboratories and Torrent Pharmaceuticals are financially stable but face challenges in growth and valuation.
  • Financially risky companies include those with high debt ratios and low margins.
Top Performers
Sun Pharmaceutical Industries Ltd.

Highest revenue growth YoY (8.42%) and strong profitability indicators with ROE at 16.13%.

Cipla Ltd.

Solid revenue growth (13.28% YoY), excellent ROE (16.63%), and low PE ratio (23.73) making it attractive.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.